Scarica l'app Stockscreener
59.72
0.37%
0.22
Dopo l'orario di chiusura:
58.57
-1.15
-1.93%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MLTX Giù?
Forum
Previsione
Precedente Chiudi:
$59.50
Aprire:
$59.52
Volume 24 ore:
677.00K
Relative Volume:
1.21
Capitalizzazione di mercato:
$3.79B
Reddito:
-
Utile/perdita netta:
$-145.21M
Rapporto P/E:
-25.97
EPS:
-2.3
Flusso di cassa netto:
$-140.12M
1 W Prestazione:
+8.98%
1M Prestazione:
+12.00%
6M Prestazione:
+48.19%
1 anno Prestazione:
+25.96%
Intervallo 1D:
$56.80
$59.97
Intervallo di 1 settimana:
$53.18
$61.87
Portata 52W:
$31.42
$61.87
Moonlake Immunotherapeutics Stock (MLTX) Company Profile
Nome
Moonlake Immunotherapeutics
Settore
Industria
Telefono
41 41 510 8022
Indirizzo
DORFSTRASSE 29, ZUG
Confronta MLTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MLTX
Moonlake Immunotherapeutics
|
59.72 | 3.72B | 0 | -145.21M | -140.12M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Moonlake Immunotherapeutics Stock (MLTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-28 | Iniziato | Rothschild & Co Redburn | Neutral |
| 2025-05-19 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2024-11-05 | Ripresa | Wedbush | Outperform |
| 2024-08-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Iniziato | Oppenheimer | Outperform |
| 2024-04-02 | Iniziato | Goldman | Neutral |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-08 | Iniziato | Citigroup | Buy |
| 2023-11-02 | Iniziato | Stifel | Buy |
| 2023-09-14 | Downgrade | Bryan Garnier | Buy → Neutral |
| 2023-08-31 | Iniziato | Needham | Buy |
| 2023-06-15 | Iniziato | Barclays | Equal Weight |
| 2023-05-01 | Iniziato | Guggenheim | Buy |
| 2023-03-22 | Iniziato | Wedbush | Outperform |
| 2023-03-09 | Iniziato | BTIG Research | Buy |
| 2023-02-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-02-02 | Iniziato | Bryan Garnier | Buy |
| 2022-11-11 | Iniziato | Jefferies | Buy |
| 2022-08-25 | Iniziato | SVB Leerink | Outperform |
| 2022-07-21 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-07 | Iniziato | Cowen | Outperform |
Mostra tutto
Moonlake Immunotherapeutics Borsa (MLTX) Ultime notizie
How hedge fund analytics apply to MoonLake Immunotherapeutics stockJuly 2025 Technicals & Real-Time Volume Triggers - Newser
How to use a screener to detect MoonLake Immunotherapeutics breakoutsJuly 2025 Spike Watch & Accurate Intraday Trade Tips - Newser
Will MoonLake Immunotherapeutics price bounce be sustainable2025 Trade Ideas & Real-Time Stock Price Movement Reports - Newser
Using data models to predict MoonLake Immunotherapeutics stock movementWeekly Market Outlook & Smart Investment Allocation Tips - Newser
MoonLake Immunotherapeutics stock daily chart insightsJuly 2025 Market Mood & Low Risk Investment Opportunities - Newser
Can technical indicators confirm MoonLake Immunotherapeutics’s reversalQuarterly Trade Summary & Capital Efficiency Focused Ideas - Newser
What Technical Tools Say About MoonLake Immunotherapeutics RecoveryQuarterly Profit Review & Precise Buy Zone Identification - beatles.ru
MoonLake Immunotherapeutics stock trend outlook and recovery pathWeekly Risk Summary & Free Real-Time Market Sentiment Alerts - Newser
What recovery options are there for MoonLake ImmunotherapeuticsTreasury Yields & Fast Entry High Yield Stock Tips - Newser
MoonLake Immunotherapeutics stock prediction for this weekTreasury Yields & Daily Market Momentum Tracking - Newser
How to track smart money flows in MoonLake ImmunotherapeuticsJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - Newser
Can MoonLake Immunotherapeutics rally from current levelsProduct Launch & Comprehensive Market Scan Reports - Newser
What Fibonacci levels say about MoonLake Immunotherapeutics reboundTrade Exit Report & Growth Focused Entry Reports - Newser
Can a trend reversal in MoonLake Immunotherapeutics lead to recoveryPortfolio Value Summary & High Accuracy Trade Signal Alerts - Newser
Visual analytics tools that track MoonLake Immunotherapeutics performanceWeekly Stock Analysis & Community Verified Trade Signals - Newser
Sentiment analysis tools applied to MoonLake ImmunotherapeuticsJuly 2025 EndofMonth & Trade Opportunity Analysis Reports - Newser
What MACD and RSI say about MoonLake ImmunotherapeuticsEarnings Miss & Consistent Growth Stock Picks - Newser
Ranking MoonLake Immunotherapeutics among high performing stocks via tools2025 Year in Review & High Accuracy Trade Alerts - Newser
How sensitive is MoonLake Immunotherapeutics to inflation2025 Price Action Summary & Growth Focused Entry Reports - khodrobank.com
MoonLake Immunotherapeutics stock hits 52-week high at 58.3 USD - Investing.com
Applying chart zones and confluence areas to MoonLake ImmunotherapeuticsDividend Hike & Safe Capital Growth Stock Tips - Newser
Forecasting MoonLake Immunotherapeutics price range with options dataJuly 2025 EndofMonth & High Conviction Buy Zone Picks - Newser
Using economic indicators to assess MoonLake Immunotherapeutics potentialJuly 2025 Action & Momentum Based Trading Ideas - Newser
Published on: 2025-09-02 03:46:56 - Newser
Can MoonLake Immunotherapeutics expand into new marketsOil Prices & Fast Momentum Stock Entry Tips - khodrobank.com
What’s the analyst consensus on MoonLake ImmunotherapeuticsQuarterly Portfolio Report & High Return Trade Guides - khodrobank.com
Is now a turning point for MoonLake ImmunotherapeuticsEarnings Growth Report & Smart Investment Allocation Insights - Newser
Will MoonLake Immunotherapeutics announce a stock splitMarket Performance Report & Precise Buy Zone Identification - khodrobank.com
Is MoonLake Immunotherapeutics forming a bottoming baseAnalyst Downgrade & Safe Swing Trade Setup Alerts - Newser
Trend Reversal Possible in MoonLake Immunotherapeutics Charts IndicateJuly 2025 Sentiment & Safe Entry Trade Reports - beatles.ru
2 Small-Cap Biotech Stocks Well Positioned for a Breakout - AOL.com
What institutional flow reveals about MoonLake ImmunotherapeuticsWeekly Trend Report & Long-Term Growth Stock Strategies - Newser
When is the best time to exit MoonLake ImmunotherapeuticsDip Buying & Fast Gain Stock Tips - Newser
Moonlake Immunotherapeutics Azioni (MLTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Moonlake Immunotherapeutics Azioni (MLTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Moukheibir Catherine | Director |
Jul 03 '25 |
Sale |
48.79 |
23,500 |
1,146,565 |
0 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):